title: In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus.
abstract: Regulatory T (Treg) cells are activated and suppress immune responses during infection, and are characterized as CD4(+)CD25(hi)FOXP3(+). Ex vivo studies demonstrate that Treg cells potentially suppress anti-HIV-1 T cell responses. Lentivirus-induced CD4(+)CD25(hi) Treg cells were first described in feline immunodeficiency virus (FIV)-infected cats. In the present study we demonstrate that anti-feline CD25 monoclonal antibody (mAb) therapy depletes Treg cells in FIV-infected cats for 4 weeks and does not exacerbate viral replication or proinflammatory cytokine production. Significant FIV-specific immune responses are revealed in Treg cell-depleted cats. These anti-FIV effector cells exist prior to Treg cell depletion and are not expanded while Treg cells are depleted. Importantly, cats receiving the Treg cell-depleting mAb are able to produce a robust humoral response to new antigen. We propose that short-term in vivo Treg cell depletion during chronic HIV-1 infection could provide a window of opportunity for therapeutic vaccination in individuals with controlled viral replication.
authors.affiliation: College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606, USA. rmikkelsen@globalvaccines.org
authors.forename: S Rochelle
authors.initials: SR
authors.lastname: Mikkelsen
authors.forename: Stacie K
authors.initials: SK
authors.lastname: Reckling
authors.forename: Erin A
authors.initials: EA
authors.lastname: Egan
authors.forename: Gregg A
authors.initials: GA
authors.lastname: Dean
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000914:Antibodies, Viral / Q000097:blood; D015704:CD4 Antigens / Q000032:analysis; D002371:Cat Diseases / Q000276:immunology* / Q000821:virology; D002415:Cats; D005260:Female; D016089:Immunodeficiency Virus, Feline / Q000276:immunology*; D053645:Interleukin-2 Receptor alpha Subunit / Q000032:analysis; D016180:Lentivirus Infections / Q000276:immunology / Q000662:veterinary*; D008212:Lymphocyte Depletion; D050378:T-Lymphocytes, Regulatory / Q000737:chemistry / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D015704:CD4 Antigens; D053645:Interleukin-2 Receptor alpha Subunit
references.citation: J Virol. 1996 Aug;70(8):5165-9
references.pmid: 8764024
references.citation: Vet Immunol Immunopathol. 1990 Dec;26(4):305-17
references.pmid: 1706120
references.citation: J Virol. 2004 Aug;78(15):8210-8
references.pmid: 15254192
references.citation: Immunity. 2005 Mar;22(3):329-41
references.pmid: 15780990
references.citation: J Immunol. 2005 Oct 1;175(7):4180-3
references.pmid: 16177055
references.citation: J Immunol. 2005 Apr 1;174(7):4407-14
references.pmid: 15778406
references.citation: Hum Immunol. 2005 Jan;66(1):13-20
references.pmid: 15620457
references.citation: Clin Exp Immunol. 2007 Mar;147(3):533-9
references.pmid: 17302904
references.citation: J Immunol. 2005 Mar 15;174(6):3143-7
references.pmid: 15749840
references.citation: Blood. 2004 Nov 15;104(10):3249-56
references.pmid: 15271794
references.citation: Nature. 2007 Feb 22;445(7130):936-40
references.pmid: 17237761
references.citation: Vet Immunol Immunopathol. 2001 May 10;79(1-2):53-67
references.pmid: 11356250
references.citation: Crit Care. 2010;14(1):R19
references.pmid: 20156359
references.citation: Immunol Rev. 2006 Aug;212:272-86
references.pmid: 16903920
references.citation: J Virol. 2008 Sep;82(17):8307-15
references.pmid: 18579608
references.citation: J Gen Virol. 2004 Sep;85(Pt 9):2585-2589
references.pmid: 15302952
references.citation: Vet Immunol Immunopathol. 2006 Jul 15;112(1-2):67-77
references.pmid: 16678276
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3390-5
references.pmid: 17360656
references.citation: Clin Microbiol Rev. 2006 Oct;19(4):728-62
references.pmid: 17041142
references.citation: Blood. 2006 Dec 1;108(12):3834-42
references.pmid: 16896154
references.citation: Vet Immunol Immunopathol. 2008 Mar 15;122(1-2):159-66
references.pmid: 18180044
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64
references.pmid: 16617117
references.citation: J Exp Med. 2007 Jun 11;204(6):1335-47
references.pmid: 17548521
references.citation: Vaccine. 2005 Feb 10;23(12):1479-90
references.pmid: 15670884
references.citation: J Exp Med. 2004 Aug 2;200(3):331-43
references.pmid: 15280419
references.citation: PLoS One. 2006 Dec 20;1:e102
references.pmid: 17183635
references.citation: Nat Immunol. 2003 Apr;4(4):330-6
references.pmid: 12612578
references.citation: J Immunol. 2004 Apr 15;172(8):4752-61
references.pmid: 15067051
references.citation: J Clin Invest. 2005 Apr;115(4):1082-91
references.pmid: 15761496
references.citation: J Clin Invest. 2004 Dec;114(11):1640-9
references.pmid: 15578096
references.citation: J Infect Dis. 2006 Mar 1;193(5):703-12
references.pmid: 16453267
references.citation: Vaccine. 2009 Jan 29;27(5):684-9
references.pmid: 19056449
references.citation: Blood. 2006 Dec 1;108(12):3808-17
references.pmid: 16902147
references.citation: Ann N Y Acad Sci. 2009 Sep;1174:99-106
references.pmid: 19769742
references.citation: Hybridoma. 1992 Oct;11(5):595-605
references.pmid: 1459583
references.citation: PLoS Biol. 2004 Jul;2(7):E198
references.pmid: 15252446
references.citation: J Virol. 2005 Apr;79(8):4965-76
references.pmid: 15795282
references.citation: J Virol. 1998 Dec;72(12):9436-40
references.pmid: 9811676
references.citation: J Exp Med. 2000 Jul 17;192(2):295-302
references.pmid: 10899916
references.citation: J Immunol. 2008 Apr 15;180(8):5439-47
references.pmid: 18390726
references.citation: J Med Genet. 2002 Aug;39(8):537-45
references.pmid: 12161590
references.citation: J Leukoc Biol. 2008 Feb;83(2):254-62
references.pmid: 17982112
references.citation: J Virol. 2004 Mar;78(5):2454-9
references.pmid: 14963140
references.citation: Virology. 2005 May 10;335(2):212-21
references.pmid: 15840520
references.citation: Cancer Invest. 2007 Sep;25(6):495-501
references.pmid: 17882663
references.citation: J Am Vet Med Assoc. 1991 Nov 15;199(10):1311-5
references.pmid: 1666073
references.citation: Semin Immunol. 2004 Apr;16(2):89-98
references.pmid: 15036232
references.citation: AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1767-78
references.pmid: 11788028
references.citation: Vet Immunol Immunopathol. 1992 Dec;35(1-2):95-119
references.pmid: 1363011
references.citation: AIDS. 2005 Jun 10;19(9):879-86
references.pmid: 15905668
references.citation: J Immunol Methods. 2005 Jul;302(1-2):36-53
references.pmid: 16023664
references.citation: J Pathol. 2008 Jan;214(2):231-41
references.pmid: 18161758
references.citation: AIDS Rev. 2007 Jan-Mar;9(1):54-60
references.pmid: 17474313
references.citation: AIDS Res Hum Retroviruses. 2007 Jul;23(7):945-52
references.pmid: 17678480
references.citation: Blood. 2007 Oct 15;110(8):2983-90
references.pmid: 17644734
references.citation: PLoS One. 2008 Oct 01;3(10):e3305
references.pmid: 18827929
references.citation: Vaccine. 2002 Dec 13;21(3-4):258-68
references.pmid: 12450701
references.citation: Nat Immunol. 2006 Mar;7(3):235-9
references.pmid: 16482171
references.citation: Vet Immunol Immunopathol. 2004 Jul;100(1-2):49-59
references.pmid: 15182995
references.citation: Eur J Immunol. 2005 Jun;35(6):1681-91
references.pmid: 15902688
references.citation: J Immunol Methods. 2008 Jan 1;329(1-2):81-91
references.pmid: 17980384
references.citation: Int Immunol. 2007 Apr;19(4):345-54
references.pmid: 17329235
references.citation: Nat Med. 2006 Mar;12(3):289-95
references.pmid: 16520776
references.citation: J Acquir Immune Defic Syndr. 2005 Aug 1;39(4):381-5
references.pmid: 16010156
references.citation: Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5138-43
references.pmid: 15790681
references.citation: J Immunol. 2008 Jan 15;180(2):764-73
references.pmid: 18178814
references.citation: Annu Rev Immunol. 2006;24:209-26
references.pmid: 16551248
references.citation: Cancer Immunol Immunother. 2009 Apr;58(4):517-30
references.pmid: 18719913
references.citation: Vet Immunol Immunopathol. 2008 Dec 15;126(3-4):263-72
references.pmid: 18799222
references.citation: Clin Microbiol Rev. 1995 Jan;8(1):87-112
references.pmid: 7704896
references.citation: J Acquir Immune Defic Syndr (1988). 1994 Oct;7(10):1003-15
references.pmid: 7916048
references.citation: Virology. 2004 Apr 10;321(2):307-22
references.pmid: 15051390
references.citation: AIDS Rev. 2006 Jul-Sep;8(3):141-7
references.pmid: 17078484